1. Joesoef AA. Vertigo. In : Harsono, editor. Kapita Selekta Neurologi.

Yogyakarta: Gadjah Mada University

Press; 2000. p.341-59
2. Korres Stavros, L. L. (2011). Benign Paroxysmal Positional Vertigo. International Journal of
Otolaryngology , 1-3.
3. Bojrab DI, Bhansali SA, Battista RA. Peripheral Vestibular Disorders. In: Jackler RK & Brackmann DE,
Editor: Textbook of Neurotology. St. Louis, Missouri : Mosby. 1994. p 629-33
4. von Brevern M, A. R. (2007). Epidemiology of benign paroxysmal positional vertigo: a population
based study. Journal Neurology Neurosurgy Psychiatry , 710715.
5. Gustaviani. Editor: Sudoyo Aru W, Setyahadi B, dkk. Xdiagnosis dan Klasifikasi
Diabetes Mellitus pada Buku Ajar Penyakit Dalam Jilid III Edisi IV hal 1879-81.
2006. Jakarta: Pusat {enerbitan Ilmu Penyakit Dalam Fakultas Kedokteran
universitas Indonesia.
6. Waspadji Sarwono. Penyulit Kronik Dan Pencegahannya. Dalam: Soegondo
Sidartawan, Soewondo Pradana, Subekti Imam. Penatalaksanaan Diabetes
Melitus Terpadu. Edisi ke-6. Jakarta : FK UI, 2007
7. Yoda Shigetoshi, S. C.-B. (2011). Association between Type 1 Diabetes Mellitus and Deposits in
the Semicircular Canal. Otolaryngology Head Neck Surgery , 1-5.
8. Delgado Mara Estela Chvez, I. V.-G.-C.-R. (2012). Cochleovestibular Dysfunction in Patients
With Diabetes Mellitus,Hypertension, and Dyslipidemia. Acta Otorrinolaringol Esp. , 93-101.
9. Bashiruddin J. Vertigo Posisi Paroksismal Jinak. Dalam : Arsyad E, Iskandar N, Editor. Telinga, Hidung
Tenggorok Kepala & Leher. Edisi Keenam. Jakarta : Balai Penerbit FKUI. 2008. Hal. 104-9
10. . Sherwood L. Telinga, Pendengaran, dan Keseimbangan. Dalam: Fisiologi Manusia dari Sel ke Sistem.
Edisi 2. Jakarta: EGC. 1996. p 176-189
11. Bashiruddin J., Hadjar E., Alviandi W. Gangguan Keseimbangan. Dalam : Arsyad E, Iskandar N, Editor :
Telinga, Hidung Tenggorok Kepala & Leher. Edisi Keenam. Jakarta : Balai Penerbit FKUI. 2008. Hal. 94-
101
12. Anderson JH dan Levine SC. Sistem Vestibularis. Dalam : Effendi H, Santoso R, Editor : Buku Ajar Penyakit
THT Boies. Edisi Keenam. Jakarta : EGC. 1997. h 39-45
13. . Johnson J & Lalwani AK. Vestibular Disorders. In : Lalwani AK, editor. Current Diagnosis & treatment in
Otolaryngology- Head & Neck Surgery. New York : Mc Graw Hill Companies. 2004. p 761-5
14. Andradi S. Terapi vertigo. Vertigo, patofisiologi, diagnosis dan terapi. Kelompok Studi Vertigo PERDOSSI
15. Moon SY, Kim JS, Kim BK, Kim JI, et al. clinical characteristic of benign paroxysmal positionalvertigo in Korea: A
multicenter study. J Korean Med Sci 2006; 21: 539-43
16. Herdman SJ, Tusa RJ. Horizontal canal BPPV. In: Diagnosis and treatment of benign paroxysmal positional vertigo. ICS
Medical Corporation, Schaumbur, Illinois 1999: 18-23
17. Furman JM, Cass SP. Benign Paroxysmal Positional Vertigo. NEJM 2009 [Available from :
http://content.nejm.org/cgi/reprint/341/21/1590.pdf
18. Mansjoer a, Triyanti K, Savitri R, Wardhani WI, Setowulan W. Penyakit Menierre. Dalam : KApita Selekta
Kedokteran. Edisi Ketiga. Jakarta : FKUI. 2001. Hal 93-94
19. Bahadir C, Diracoglu D, Kurtulus D, Garipoglu I. Efficacy of canalith repositioning maneuvers for banign paroxysmal
positional vertigo. Clinical Chiropractic 2009; 12: 95-100
20. . Appiani CG, Catania G, Gagliardi M, Cuiuli G. repositioning maneuver for the treatment of the apogeotropic variant of
horizontal canal benign paroxysmal positional vertigo. Otology & Neurotology 2005; 26:257-60
21. Perkumpulan Endokrinologi Indonesia. Konsensus Pengelolaan dan
Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2006. PB PERKENI, Jakarta
2006 : 1-47
22. ADA (American Diabetes Association). 2011. Diagnosis and Classification of Diabetes Mellitus; doi:
10.2337/diacare.27.2007.S5 Diabetes Care january 2004 vol. 27 mo. Suppl 1 s5-s10. Avalilable from:
http://care.diabetesjournals.org/content/27/suppl_1/s5,full
23. American Diabetes Association. Standard of Medical Care in Diabetes 2008.
diabetes Care Vol.31, 2008, Supplement
24. Leahy JL. Pathogenesis of Type 2 Diabetes Mellitus. In : Feinglos MN, Bethel
MA. Type 2 Diabetes Mellitus, An Evidence-Based Approach to Practical
Management. Humana Press, USA 2008 : 17-34.
25. World Health Organization. Definition and Diagnosis of Diabetes Mellitus and
Intermediate Hyperglycemia : Report of WHO/IDF Consultation. World Health
Organization, Geneva, Switzerland 2006 : 1-35.
26. Gustaviani R. Diagnosis dan Klasifikasi Diabetes Melitus. Dalam : Buku Ajar Ilmu
Penyakit Dalam. Pusat Penerbitan Ilmu Penyakit Dalam FKUI Jakarta 2006
:1857-1859.
27. Bennet PH, Knowler WC. Definition, Diagnosis and Classification of Diabetes
Mellitus and Glucose Homeostasis. In: Joslins Diabetes Mellitus 14th ed.
Lippincott Williams & Wilkins, USA 2006 : 332-41.
28. The Royal College of General Practitioners Effective Clinical Practice Unit: Clinical guidelines for type 2 diabetes
mellitus: management of blood glucose [article online], 2002. Available from
29. Sheehan MT: Current therapeutic options in type 2 diabetes mellitus: a practical approach. Clin Med Res 1:189
200, 2003
30. Groop L: Sulfonylureas in NIDDM. Diabetes Care 15:737747, 1992
31. Malaisse WJ: Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus. Treat
Endocrinol 2:401414, 2003
32. Yki-Jarvinen H: Drug therapy: thiazolidinediones. N Engl J Med351:1106, 2004Bailey CJ, Turner RC:
Metformin. N Engl J Med 334:574583, 1996
33. Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C:
Alpha-glucosidase inhibitors for type 2 diabetes mellitus.Cochrane Database Syst
Rev CD003639, 2005
34. ollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson J-L, Levin SR: Efficacy and safety of
inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes. Diabetes
Care 27:2562363, 2004
35. Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, Bode B, Garber A: Initiating insulin therapy in type 2
diabetes. Diabetes Care28:260265, 2005
36. Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan S-P, Cefalu WT: Inhaled
insulin improves glycemic control when substituted for or added to oral combination therapy in type 2
diabetes. Ann Intern Med 143:549558, 2005